LDOS Stock Recent News

Leidos (LDOS) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, LDOS broke through the 200-day moving average, which suggests a long-term bullish trend.

In the closing of the recent trading day, Leidos (LDOS) stood at $156.09, denoting a +0.19% change from the preceding trading day.

Leidos (LDOS) possesses solid growth attributes, which could help it handily outperform the market.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

RESTON, Va. , Sept. 3, 2024 /PRNewswire/ --  Leidos  (NYSE:LDOS), a Fortune® 500 innovation company, was recently awarded the National Healthcare Safety Network (NHSN) Development, Maintenance, Support, and Modernization contract by the Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Leidos (LDOS) reported earnings 30 days ago. What's next for the stock?

Aerospace-Defense stocks ride high on impressive air passenger view and solid US defense budget amid the adverse impacts of supply-chain challenges. You may buy LDOS, SPCE and AIRI.

LDOS gets a $51 million contract from Space Systems Command, Strategic Warning and Surveillance Systems Acquisition Delta for improving missile capabilities.

Leidos (LDOS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.